Alliance Pharma (LSE:APH) Cash Flow for Dividends : £0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma Cash Flow for Dividends?

Alliance Pharma's cash flow for dividends for the six months ended in Dec. 2024 was £0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was £0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Alliance Pharma's quarterly payment of dividends declined from Dec. 2023 (£-6.4 Mil) to Jun. 2024 (£0.0 Mil) but then stayed the same from Jun. 2024 (£0.0 Mil) to Dec. 2024 (£0.0 Mil).

Alliance Pharma's annual payment of dividends increased from Dec. 2022 (£-9.1 Mil) to Dec. 2023 (£-9.6 Mil) but then declined from Dec. 2023 (£-9.6 Mil) to Dec. 2024 (£0.0 Mil).

Alliance Pharma Cash Flow for Dividends Historical Data

The historical data trend for Alliance Pharma's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma Cash Flow for Dividends Chart

Alliance Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Dividends

Get a 7-Day Free Trial

-2.84

-8.60

-9.12

-9.59

Alliance Pharma Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash Flow for Dividends	Get a 7-Day Free Trial															-6.09	-3.20	-6.40	-	-

Alliance Pharma Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.0 Mil.

Alliance Pharma Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Alliance Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

DVL:Germany

Address

Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB

Website

https://www.alliancepharmaceuticals.com

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. The company generates the majority of its revenue from the Consumer Healthcare segment. The products of the company include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, Fazol, and others. Geographically, the company derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).